All In Biotech

Drug Trial Radar · NCT02134977

Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"

Last checked: Nov 19, 2026Latest source record: Oct 18, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

2,816

Actual

Start

Sep 2011

Primary completion

Mar 2015

Study completion Mar 2015

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
May 9, 2014

More drug trials from this sponsor

Design

Study type
Observational
Who can join
Female only
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this survey is to examine the effect on quality of life (QOL) improvement and convenience of switching to leuprorelin acetate 3 months depot 11.25 milligram (mg) injection kit (Leuplin SR 11.25 mg injection kit) from a 4-week adjuvant therapy with a luteinizing hormone-releasing hormone analog (LH-RHa) 1 month depot over 48 weeks in premenopausal breast cancer participants in daily medical practice. Influence of condition of estrogen receptor expression on the efficacy and safety of leuprorelin acetate SR 11.25 mg injection kit was also evaluated.

Conditions

  • Breast Cancer

Interventions

  • Leuprorelin AcetateDrug

    Leuprorelin Acetate SR 11.25 mg Injection Kit

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Quality of Life Questionnaire for Cancer Patients Treated With Anticancer Drugs (QOL-ACD) Total and Subscale Score at BaselineTime frame: Baseline
  2. QOL-ACD Total and Subscale Score at Week 12Time frame: Week 12
  3. QOL-ACD Total and Subscale Score at Week 48Time frame: Week 48
  4. QOL-ACD Breast (QOL-ACD-B) Score at BaselineTime frame: Baseline
  5. Score of QOL-ACD-B at Week 12Time frame: Week 12
  6. Score of QOL-ACD-B at Week 48Time frame: Week 48
  7. Score of QOL-ACD-B Items 19, 20 and 21 at BaselineTime frame: Baseline
  8. Score of QOL-ACD-B Items 19, 20 and 21 at Week 12Time frame: Week 12
  9. Score of QOL-ACD-B Items 19, 20 and 21 at Week 48Time frame: Week 48

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.